title: Thrombin promotes the expression of thrombospondin-1 and -2 in a rat model of intracerebral hemorrhage.
abstract: Spontaneous intracerebral hemorrhage (ICH) is one of the most severe types of stroke. Thrombin has been reported to participate in brain repair following ICH and play an important role in angiogenesis. Our previous studies have shown that ICH induces angiogenesis in damaged rat brain, accompanied by upregulation of expression of thrombospondin (TSP)-1 and TSP-2. The aim of the present study was to investigate whether the expression of TSP-1 and TSP-2 was regulated by thrombin in rat brain following ICH. A rat model of ICH was induced by injection of autologous blood into the right globus pallidus (GP). Hirudin, a thrombin specific inhibitor, or thrombin was injected into the GP. Immunohistochemistry, quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR) and western blot assays were applied. Results showed that ICH induced an increase in the expression of TSP-1 mRNA and TSP-2 mRNA after ICH, whereas hirudin significantly inhibited the expression of TSPs mRNA after ICH (P<0.05). In contrast, sole thrombin treatment in normal rats induced strong expression of TSP-1 or TSP-2 in the blood vessels around the damaged brain region when compared with those without thrombin treatment. Western blot analysis data confirmed that the protein levels of TSPs were significantly increased when compared with those in the sham control group (P<0.01). These findings support that thrombin positively regulates the expression of TSP-1 and TSP-2 after ICH, which may be involved in modulating angiogenesis in injured brains following ICH.
authors.affiliation: Institute of Integrative Medicine, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China.
authors.forename: A-Li
authors.initials: AL
authors.lastname: Yang
authors.forename: Hua-Jun
authors.initials: HJ
authors.lastname: Zhou
authors.forename: Yuan
authors.initials: Y
authors.lastname: Lin
authors.forename: Jie-Kun
authors.initials: JK
authors.lastname: Luo
authors.forename: Han-Jin
authors.initials: HJ
authors.lastname: Cui
authors.forename: Tao
authors.initials: T
authors.lastname: Tang
authors.forename: Qi-Dong
authors.initials: QD
authors.lastname: Yang
mesh_terms: D000818:Animals; D000991:Antithrombins / Q000494:pharmacology; D001808:Blood Vessels / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006629:Hirudins / Q000494:pharmacology; D008297:Male; D018919:Neovascularization, Physiologic; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D060888:Real-Time Polymerase Chain Reaction; D013917:Thrombin / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D019700:Thrombospondin 1 / Q000096:biosynthesis* / Q000235:genetics; D019699:Thrombospondins / Q000096:biosynthesis* / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects*; D000099262:Thrombospondin 2
chemical_list: D000991:Antithrombins; D006629:Hirudins; D012333:RNA, Messenger; D013917:Thrombin; D019700:Thrombospondin 1; D019699:Thrombospondins; D000099262:Thrombospondin 2